[Syn+ec+tics]:- an approach to solving problems based on the creative thinking of a group of people from different areas of expertise and knowledge......
At Synectix Pharmaceutical Solutions Ltd, we develop 'new generation' pharmaceutical and biopharmaceutical products using our proprietary drug formulation technologies, which are specifically applied to enhance the delivery and performance of poorly soluble and hydrophobic new chemical entities (NCEs) and commercial compounds showing poor bioavailability, as well as rescuing potential R&D drop-outs.
Our core research efforts are focused on the application of novel particle processing and 'drug activation' technologies to produce stable soluble intermediates for liquid, solid and semi-solid dosage forms. Using these bespoke technologies, we turn problematic and hard to develop drug candidates into easy to administer, stable and successful pharmaceutical products.
Our drug delivery technologies for solubility / bioavailability enhancement include:
SOLENT™ ARRAY
High-throughput preclinical formulation screening platform for solubility enhancment of hydrophobic / lipophilic APIs
Learn more >>> |
LENA™ NANOCEUTICS
Crystalline nanoparticulate suspensions and dry powder formulations for dissolution velocity enhancement of hydrophobic APIs
Learn more >>> |
PRORELEASE™ ASD
Stabilised amorphous solid solution intermediates for bioavailability enhancement of low solubility, hydrophobic APIs
Learn more >>> |
